Risk of Venous Thromboembolism with Statins: Evidence Gathered via a Network Meta-analysis.

Oğuzhan Birdal Mehmet Saygı Remziye Doğan Ozan Tezen Ali Karagöz Halil Ibrahim Tanboga

Published in: Balkan medical journal (2023)

Rosuvastatin is significantly reduces the risk of VTE when compared with a placebo, other statin subtypes, and fibrate. Furthermore, fenofibrate increased the VTE risk when compared with a placebo and statins.

Keyphrases

venous thromboembolism
cardiovascular disease
direct oral anticoagulants
double blind
phase iii
placebo controlled
coronary artery disease
clinical trial
randomized controlled trial
study protocol